top of page


Neurotrauma and Global Neurosurgery International Fellowship Application

Neurosurgeons from low and middle income countries  with basic proficiency in english are encouraged to apply.


In order to be an applicant for the Fellowship, the application form needs to be completely filled out including all the additional documents that are required, like curriculum vitae, personal statement, letters of recommendation and certification of a neurological surgery program in the applicants original country.

Our Directors

Rubiano NO logo.jpg
Andres M. Rubiano, MD
P. David Adelson, MD

Is the Director of the Foundation for Medical Education and Research in Colombia.

Dr. Rubiano is a neurosurgeon and neuroscience professor at Universidad El Bosque, being also Research Director for Neurotrauma at the Neuroscience Institute at the same institution in Bogota, Colombia.


Dr. Rubiano is a recognized expert on traumatic brain injury and has been in honorary positions as chair of the Neurotrauma Chapter of the Colombian Neurosurgery Association, chair of the Trauma and Intensive Care Chapter of the Latin American Federation of Neurosurgical Societies and Chair of the International Committee of the Neurotrauma and Critical Care Section of the American Association of Neurological Surgeons.


More information about Dr. Rubiano's publications is available at:

Andres M. Rubiano, MD Publications

Is Director of Barrow Neurological Institute at Phoenix Children’s Hospital, Diane and Bruce Halle Endowed Chair for Pediatric Neurosciences and Chief of Pediatric Neurosurgery at Phoenix Children's Hospital


In 2016, he was the first pediatric neurosurgeon to be awarded the highly coveted Herbert Olivecrona Award, the Nobel Prize of Neurosurgery, by the Department of Clinical Neuroscience/Neurosurgery at Karolinska Institutet in Stockholm, Sweden. Dr. Adelson was chosen for his vast clinical and research contributions to the field of pediatric neurosurgery and significant work in pediatric neuroscience research. He has served as President for the Congress of Neurological Surgeons and President of the Neurotrauma Section of the AANS.


More information about Dr. Adelson's affiliations and publications is available at:

P. David Adelson, MD Publications

Research Co-Directors

Peter J. Hutchinson, MD, PhD
United Kingdom

Is a NIHR Research Professor at the Department of Clinical Neurosciences, University of Cambridge and Honorary Consultant Neurosurgeon at Addenbrooke's Hospital, Cambridge. He have a general neurosurgical practice with a subspecialist interest in the management of patients with neurological trauma. His research interests include traumatic brain injury (Chief Investigator of the MRC/NIHR-funded RESCUEicp decompressive study), multimodality monitoring in neurocritical care, and functional brain imaging.


He was the previous Chair of the European Association of Neurological Societies (EANS) Research Committee and Vice President of the EANS. He is also the Neurosurgical Specialty Lead at the Royal College of Surgeons of England; Chair of the Society of British Neurological Surgeons (SBNS) Neurotrauma Group; member of the SBNS Council; Director of Clinical Studies and Fellow at Robinson College, Cambridge; He has been also Chief Medical Officer for the Formula 1 British Grand Prix

More information about Dr. Hutchinson's publications is available at:

Peter Hutchinson, MD, PhD Publications

Angelos Kolias,  MD, PhD
United Kingdom

Angelos Kolias MD, PhD, is a Clinical Lecturer in Neurosurgery. His research aims to evaluate the clinical effectiveness and understand the mechanisms of action of interventions for traumatic brain injury incluidng elements like Acute TBI and Traumatic intracranial hypertension.

He was the research fellow of the RESCUEicp trial and his PhD was focused on decompressive craniectomy for traumatic intracranial hypertension. He is also the  Co-CI of the RESCUE-ASDH trial ( for primary DC for ASDH and he is part of the Subacute and chronic TBI (chronic subdural haematomas; CSDH study). This project aims to develop a ‘core outcome set’, which represents the minimum that should be reported in clinical trials of CSDH. He is also the Co-CI of the Dex-CSDH trial of dexamethasone for CSDH (

More information about Dr. Kolias publications is available at:

Angelos Kolias, MD, PhD Publications

bottom of page